Relapsed Sarcomas: Clinical Trials

1 trial for Relapsed Sarcomas, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow Relapsed Sarcomas: new trials by email Literature Review of Relapsed Sarcomas trials Research Report on Relapsed Sarcomas

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
Disulfiram, Copper Gluconate, Liposomal Doxorubicin (Doxil) - Relapsed Sarcomas
Phase 1RecruitingCase Comprehensive Cancer Center242023-03-092026-08-06

Narrower conditions

Osteosarcoma (1)  ·  Rhabdomyosarcoma (1)  ·  Sarcoma (1)  ·  Sarcoma, Ewing (1)

Broader conditions

Myosarcoma (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Bone Tissue (1)  ·  Neoplasms, Connective Tissue (1)  ·  Neoplasms, Connective and Soft Tissue (1)  ·  Neoplasms, Muscle Tissue (1)

Interventions

Disulfiram (1)  ·  Gluconates (1)  ·  liposomal doxorubicin (1)

Sponsors

Case Comprehensive Cancer Center (1)

Countries

United States (1)

Top investigators

Matteo Trucco, MD (1)